And that means taking on the middlemen who profit when prices get high and making sure that savings Medicare negotiates actually reach the patient, not just the executives. This is why I'm working with my colleagues to build the next generation of drug pricing reform. So savings aren't just theoretical and they aren't delayed, but they show up where they matter, immediately in the pocketbooks of American families. We can do this without stifling innovation. (03:21–03:26)
CLAIM
Asserts that Ruben Gallego is actively involved in legislative efforts to reform drug pricing.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
